Ergoteles LLC Bio Rad Laboratories, Inc. Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$359.49 - $486.4 $719,698 - $973,772	-2,002 Reduced 49.54%	2,039 $773,000
Q1 2023 May 10, 2023	SELL	$418.69 - $503.0 $1.98 Million - $2.38 Million	-4,728 Reduced 53.92%	4,041 $1.94 Million
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $2.6 Million - $3.37 Million	7,388 Added 534.97%	8,769 $3.69 Million
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $569,786 - $777,862	1,381 New	1,381 $576,000
Q1 2021 May 12, 2021	SELL	$547.01 - $662.35 $711,113 - $861,055	-1,300 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$510.68 - $643.45 $663,884 - $836,485	1,300 New	1,300 $758,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.